Matinas BioPharma Holdings, Inc. (MTNB)
2.64
+0.22
(+9.09%)
USD |
NYAM |
Oct 02, 16:00
2.83
+0.19
(+7.20%)
After-Hours: 20:00
Matinas BioPharma Holdings Price to Book Value : 0.6264 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.6264 |
| October 01, 2026 | 0.5742 |
| September 30, 2026 | 0.6051 |
| September 29, 2026 | 0.6834 |
| September 28, 2026 | 0.6003 |
| September 25, 2026 | 0.5695 |
| September 24, 2026 | 0.6335 |
| September 23, 2026 | 0.6229 |
| September 22, 2026 | 0.63 |
| September 21, 2026 | 0.6189 |
| September 18, 2026 | 0.5709 |
| September 17, 2026 | 0.5801 |
| September 16, 2026 | 0.5876 |
| September 15, 2026 | 0.5695 |
| September 14, 2026 | 0.6834 |
| September 11, 2026 | 0.6584 |
| September 10, 2026 | 0.7296 |
| September 09, 2026 | 0.6538 |
| September 08, 2026 | 0.6478 |
| September 04, 2026 | 0.6478 |
| September 03, 2026 | 0.6442 |
| September 02, 2026 | 0.662 |
| September 01, 2026 | 0.7036 |
| August 31, 2026 | 0.7036 |
| August 28, 2026 | 0.7118 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.7118 |
| August 26, 2026 | 0.699 |
| August 25, 2026 | 0.7022 |
| August 24, 2026 | 0.6994 |
| August 21, 2026 | 0.7076 |
| August 20, 2026 | 0.6495 |
| August 19, 2026 | 0.8578 |
| August 18, 2026 | 0.725 |
| August 17, 2026 | 0.7908 |
| August 14, 2026 | 0.8328 |
| August 13, 2026 | 0.8293 |
| August 12, 2026 | 0.8542 |
| August 11, 2026 | 0.9325 |
| August 10, 2026 | 0.9574 |
| August 07, 2026 | 1.007 |
| August 06, 2026 | 0.9553 |
| August 05, 2026 | 0.9788 |
| August 04, 2026 | 1.034 |
| August 03, 2026 | 1.073 |
| July 31, 2026 | 1.046 |
| July 30, 2026 | 1.130 |
| July 29, 2026 | 1.060 |
| July 28, 2026 | 1.043 |
| July 27, 2026 | 1.182 |
| July 24, 2026 | 0.8592 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Savara, Inc. | 6.877 |
| Vericel Corp. | 5.552 |
| Biogen, Inc. | 1.723 |
Price to Book Value Related Metrics
| Price | 2.64 |
| Earnings Yield | -682.3% |
| Market Cap | 1.128M |